In this Q&A, Ping Moore, OD, covers emerging dry eye therapies, from selenium sulfide to next-gen cyclosporine, and how subtype-guided care shapes treatment choices.
|Articles|September 4, 2019
Episode 9: Why intense pulsed light therapy is ideal for treating chalazion
Author(s)Julianne Mobilian
In our latest episode, Laura M. Periman, MD, shares her experience using intense pulsed light (IPL) therapy, and the benefits she's found in it for treating patients with chalazion.
Advertisement
In our latest episode,
Watch more of her take on IPL therapy from the annual ASCRS meeting in San Diego earlier this year.
Listen to more
Advertisement
Related to this article
Two investigational pipeline therapies take aim at the root causes of dry eye disease
Dry eye care pivots to root-cause diagnosis and personalized biologics/devices,
Findings from the third annual State of Dry Eye survey link symptom management to quality of life gains, including lower anxiety and improved self-confidence.
Dry eye cases rise with heavy screen use and younger patients; learn modern workups spotlighting MGD, etiology-driven treatments, and collaborative care reshaping outcomes.
Patients with polyendocrine metabolic ovarian syndrome have higher ocular disease prevalence.
Optometrist–ophthalmologist co-management targets dry eye early, improves cataract and refractive surgery satisfaction, and uses advanced diagnostics and treatments for healthier ocular surfaces.
Their conversation covers a holistic, cross-specialty approach to ocular surface disease and the unmet need driving a new model of dry eye care in Ireland.
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
AAO 2026: How to become an ocular pain detective in dry eye
2
AAO 2026: Tinlarebant in Stargardt disease: Jacque Duncan, MD, on DRAGON results
3
Alvotech files first known aflibercept 8 mg biosimilar with EMA
4
How ophthalmology researchers are applying RWD to power new insights
5